<DOC>
	<DOCNO>NCT02446054</DOCNO>
	<brief_summary>Evaluation change patient ' glycosylated hemoglobin ( HbA1c ) 12 week diet control</brief_summary>
	<brief_title>A Study Evaluate Effect Musashino Diabetes Diet Type II Diabetes Mellitus Disease</brief_title>
	<detailed_description>In study , provide delivery service Musashino T2DM diet 12 week patient T2DM , evaluate effect glycosylated hemoglobin ( HbA1c ) , progression compliance study period .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>A baseline glycosylated hemoglobin ( HbA1c ) , 10 % ≥HbA1c≥7 % , past 1 month The subject able understand comply protocol requirement , instrument The subject and/or subject 's primary caregiver able telephone interview use computer internet ass Signed date write informed consent Pregnancy , breastfeed plan become pregnant study Acute illness infection require treatment within 14 day study entry Other serious disease ( e.g . Heart , lung , brain , liver ) within 3 month Presence malignancy Participate clinical trial within 30 day prior study Alcohol drug abuse would interfere ability meet study requirement ( opinion investigator ) Concurrent significant medical condition would limit ability participate study Consider investigator unsuitable study participation , reason</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>T2DM , type II diabetes Mellitus , HbA1c</keyword>
</DOC>